Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 07:46 am Sale |
2021-12-31 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
51,888,455 5.420% |
-123,696 (-0.24%) |
Filing History |
| 2022-02-10 4:29 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
ELI LILLY & Co LLY |
339,191 0.700% |
339,191 (New Position) |
Filing History |
| 2022-02-10 4:26 pm Purchase |
2021-12-31 | 13G | Surface Oncology, Inc. SURF |
ELI LILLY & Co LLY |
1,593,997 3.500% |
1,593,997 (New Position) |
Filing History |
| 2022-02-10 4:21 pm Unchanged |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
ELI LILLY & Co LLY |
2,319,396 4.900% |
0 (Unchanged) |
Filing History |
| 2022-02-10 4:16 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
ELI LILLY & Co LLY |
3,151,605 3.500% |
3,151,605 (New Position) |
Filing History |
| 2022-02-10 4:13 pm Purchase |
2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
ELI LILLY & Co LLY |
61,061 3.100% |
61,061 (New Position) |
Filing History |
| 2022-02-10 4:05 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
ELI LILLY & Co LLY |
2,548,145 5.800% |
2,548,145 (New Position) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Eli Lilly and Company LLY |
The Vanguard Group | 69,261,754 7.240% |
600,260 (+0.87%) |
Filing History |
| 2022-02-08 5:12 pm Purchase |
2021-12-31 | 13G | Eli Lilly and Company LLY |
BlackRock Inc. BLK |
63,877,023 6.700% |
5,065,255 (+8.61%) |
Filing History |
| 2022-01-27 4:56 pm Sale |
2021-12-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 107,463,810 11.230% |
-3,668,533 (-3.30%) |
Filing History |
| 2021-12-13 08:16 am Purchase |
2021-12-10 | 13G | Foghorn Therapeutics Inc. FHTX |
ELI LILLY & Co LLY |
4,000,000 9.700% |
4,000,000 (New Position) |
Filing History |
| 2021-09-10 1:03 pm Purchase |
2021-09-03 | 13G | ProQR Therapeutics N.V. PRQR |
ELI LILLY & Co LLY |
3,989,976 5.600% |
3,989,976 (New Position) |
Filing History |
| 2021-02-12 4:50 pm Purchase |
2020-12-31 | 13G | AC Immune SA ACIU |
ELI LILLY & Co LLY |
3,615,328 5.000% |
3,615,328 (New Position) |
Filing History |
| 2021-02-12 4:43 pm Purchase |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
ELI LILLY & Co LLY |
2,319,396 6.200% |
2,319,396 (New Position) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX |
ELI LILLY & Co LLY |
211,111 8.800% |
211,111 (New Position) |
Filing History |
| 2021-02-12 08:44 am Sale |
2020-12-31 | 13G | Eli Lilly and Company LLY |
PNC FINANCIAL SERVICES GROUP INC. PNC |
52,012,151 5.440% |
-118,501 (-0.23%) |
Filing History |
| 2021-02-10 10:52 am Sale |
2020-12-31 | 13G | Eli Lilly and Company LLY |
The Vanguard Group | 68,661,494 7.180% |
-2,258,556 (-3.18%) |
Filing History |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | Eli Lilly and Company LLY |
BlackRock Inc. BLK |
58,811,768 6.100% |
-2,067,444 (-3.40%) |
Filing History |
| 2021-01-21 2:30 pm Sale |
2020-12-31 | 13G | Eli Lilly and Company LLY |
LILLY ENDOWMENT INC | 111,132,343 11.620% |
-3,428,256 (-2.99%) |
Filing History |
| 2021-01-08 06:04 am Purchase |
2021-01-06 | 13G | Precision BioSciences, Inc. DTIL |
ELI LILLY & Co LLY |
125,406 7.165% |
125,406 (New Position) |
Filing History |